U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

  1. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - Pediatric cardiac surgery A total of 40 patients received rFVIIa prophylaxis in one poor quality RCT

  2. Paul Tedrick (doc file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/mindfulness-transcript.doc
    June 10, 2014 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis

  3. Mindfulness: Engaging Frontline Providers in Antimicrobial Stewardship (June 10, 2014) | Agency for Healthcare Research and Quality

    www.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
    December 01, 2017 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis

  4. Paul Tedrick (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/mindfulness-transcript.doc
    June 10, 2014 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis

  5. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - At that time, the Task Force found insufficient evidence to recommend for or against routine aspirin prophylaxis … Concomitant use of other nonsteroidal anti-inflammatory agents or anticoagulants further increased risk … Aspirin for the Primary Prevention of Cardiovascular Events 24 Adults without known CVD Aspirin prophylaxis

  6. Dietary-Supplements Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - concomitant prescription drugs from, on average, 5.9 different drug classes for primary and secondary prophylaxis … : 40-55 years Mixed gender Unclear CHD risk 6-25 weeks treatment INR Vitamin K (150 μg /day) + Anticoagulants … combination with antiplatelet agents (acetylsalicylic acid,65,66 clopidogrel,67 or ticlopidine68), an anticoagulant … Overall evidence indicates that supplementation with vitamin K may improve the stability of anticoagulant … or withdrawal due to adverse events.41 This study recruited 70 participants with indications for anticoagulant

  7. Dietary-Supplements Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - concomitant prescription drugs from, on average, 5.9 different drug classes for primary and secondary prophylaxis … : 40-55 years Mixed gender Unclear CHD risk 6-25 weeks treatment INR Vitamin K (150 μg /day) + Anticoagulants … combination with antiplatelet agents (acetylsalicylic acid,65,66 clopidogrel,67 or ticlopidine68), an anticoagulant … Overall evidence indicates that supplementation with vitamin K may improve the stability of anticoagulant … or withdrawal due to adverse events.41 This study recruited 70 participants with indications for anticoagulant

  8. Health Information Exchange Utilization and Inter-hospital Transfer Outcomes - Final Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/r01hs026732-usher-final-report-2023.pdf
    January 01, 2023 - ; 95% CI, 0.66-0.99) and the use of COVID-19–specific therapeutics including deep vein thrombosis prophylaxis

  9. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - However, we more clearly identify where on the continuum of prophylaxis-treatment-end-stage these studies … While some studies might hint towards an early intervention (e.g., in prophylaxis use) in high-risk

  10. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - However, we more clearly identify where on the continuum of prophylaxis-treatment-end-stage these studies … While some studies might hint towards an early intervention (e.g., in prophylaxis use) in high-risk

  11. Assessing the Accuracy of Google Translate To Allow Data Extraction From Trials Published in Non-English Languages (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-extraction-google_research.pdf
    January 01, 2013 - Cardiac function Colorectal cancer Diabetes mellitus education Diabetes mellitus prevention Fungal prophylaxis … [Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia … Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT

  12. Mindfulness: Engaging Frontline Providers in Antimicrobial Stewardship (June 10, 2014) | Agency for Healthcare Research and Quality

    ce.effectivehealthcare.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
    December 01, 2017 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis

  13. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - estimated 2.7 million to 6.1 million patients who currently have AF have one or more contraindications to anticoagulants … About half of the patients with contraindications to anticoagulants (550,000 to 1.2 million) are at … expected to be diagnosed each year, and if 40% (64,000) of these new cases have contraindications to anticoagulants … Centers for Disease Control and Prevention (CDC) recommends pre-exposure prophylaxis (PrEP) for males

  14. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - estimated 2.7 million to 6.1 million patients who currently have AF have one or more contraindications to anticoagulants … About half of the patients with contraindications to anticoagulants (550,000 to 1.2 million) are at … expected to be diagnosed each year, and if 40% (64,000) of these new cases have contraindications to anticoagulants … Centers for Disease Control and Prevention (CDC) recommends pre-exposure prophylaxis (PrEP) for males

  15. Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer
    April 11, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

  16. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

  17. CERs Report cover (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant

  18. Future Research Needs Document (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant

  19. CERs Report cover (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant

  20. Future Research Needs Document (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (106)

psnet.ahrq.gov (62)

cmext.ahrq.gov (60)

effectivehealthcare-admin.ahrq.gov (59)

ce.effectivehealthcare.ahrq.gov (53)

effectivehealthcare.ahrq.gov (46)

www.uspreventiveservicestaskforce.org (20)

www.qualitymeasures.ahrq.gov (17)

digital.ahrq.gov (10)

pbrn.ahrq.gov (8)

pcmh.ahrq.gov (8)

www.cpsi.ahrq.gov (8)

ahrqpubs.ahrq.gov (7)

cahps.ahrq.gov (7)

healthcare411.ahrq.gov (7)

monahrq.ahrq.gov (7)

patientregistry.ahrq.gov (7)

qualityindicators.ahrq.gov (6)

talkingquality.ahrq.gov (6)

www.cahps.ahrq.gov (6)

preventiveservices.ahrq.gov (5)

teamstepps.ahrq.gov (5)

www.healthcare411.ahrq.gov (5)

www.innovations.ahrq.gov (5)

www.monahrq.ahrq.gov (5)

www.talkingquality.ahrq.gov (5)

cds.ahrq.gov (3)